首页 › 癌症（所有类型） › 内布拉斯加州 › Omaha
Omaha NE 癌症（所有类型）临床试验
18项针对 癌症（所有类型）的研究正在 Omaha及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- Nebraska Medicine, Omaha
- Nebraska Medicine - Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
招募中3 期
- University of Nebraska Medical Center, Omaha
- Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- University of Nebraska Medical Center, Omaha
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- University Of Nebraska Medical Center, Omaha
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
招募中2 期
- University of Nebraska Medical Center, Omaha
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- Nebraska Cancer Specialists, Omaha
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
招募中1 期
- Nebraska Cancer Specialists, Omaha
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- 以及另外 8 项
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
招募中1/2 期
- Nebraska Cancer Specialists, Omaha
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- Fred and Pamela Buffett Cancer Center, Omaha
GEMINI-NSCLC: NSCLC Biomarker Study
招募中观察性研究
- Nebraska Cancer Specialists, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Omaha
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of Nebraska Medical Center, Omaha
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
招募中观察性研究
- Nebraska Cancer Specialists, Omaha
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medicine, Omaha
- Nebraska Medicine - Bellevue, Bellevue · 距离 9 英里
其他城市的 癌症（所有类型）试验
- Houston, TX121 项研究
- New York City, NY110 项研究
- Boston, MA86 项研究
- Los Angeles, CA73 项研究
- Nashville, TN65 项研究
- Philadelphia, PA59 项研究
- Durham, NC58 项研究
- Washington, DC58 项研究
- Chicago, IL51 项研究
- Seattle, WA49 项研究
- Atlanta, GA49 项研究
- Arlington, VA48 项研究
Omaha的其他研究
- 前列腺癌27 项研究
- 非小细胞肺癌24 项研究
- 乳腺癌22 项研究
- 结直肠癌18 项研究
- 多发性骨髓瘤16 项研究
- 非霍奇金淋巴瘤14 项研究
- 卵巢癌14 项研究
- 胰腺癌14 项研究
- 头颈鳞状细胞癌13 项研究
- 心力衰竭13 项研究
- 转移性癌症13 项研究
- 肾癌（肾细胞癌）12 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。